Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Boehringer Ingelheim
Scientific Title
A Phase II/III, Randomized, Open-label, Multi-center Study of BI 907828 Compared to Doxorubicin as First Line Treatment of Patients With Advanced Dedifferentiated Liposarcoma